Literature DB >> 16672427

Increasing incidence of severe Epstein-Barr virus-related infectious mononucleosis: surveillance study.

Pierre Tattevin1, Yves Le Tulzo, Sophie Minjolle, Arnaud Person, Jean Marc Chapplain, Cedric Arvieux, Remi Thomas, Christian Michelet.   

Abstract

Older patients are more susceptible to severe Epstein-Barr virus (EBV)-related infectious mononucleosis (IM). This condition may increase in industrialized countries where primary EBV infection occurs later in life. Between 1990 and 2004, 38 patients were admitted to our department with EBV-related IM. Two patients died. The annual incidence increased significantly (r = 0.623; P = 0.013).

Entities:  

Mesh：

Year:  2006        PMID： 16672427      PMCID： PMC1479173          DOI： 10.1128/JCM.44.5.1873-1874.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

Authors:  S Imashuku; K Kuriyama; T Teramura; E Ishii; N Kinugawa; M Kato; M Sako; S Hibi
Journal:  J Clin Oncol       Date:  2001-05-15       Impact factor: 44.544

2.  The changing epidemiology of infectious mononucleosis?

Authors:  M C Morris; W J Edmunds
Journal:  J Infect       Date:  2002-08       Impact factor: 6.072

3.  Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study.

Authors:  E Tynell; E Aurelius; A Brandell; I Julander; M Wood; Q Y Yao; A Rickinson; B Akerlund; J Andersson
Journal:  J Infect Dis       Date:  1996-08       Impact factor: 5.226

4.  Clinical and laboratory presentation of EBV positive infectious mononucleosis in young adults.

Authors:  I Grotto; D Mimouni; M Huerta; M Mimouni; D Cohen; G Robin; S Pitlik; M S Green
Journal:  Epidemiol Infect       Date:  2003-08       Impact factor: 2.451

5.  Infectious mononucleosis in middle age.

Authors:  P G Auwaerter
Journal:  JAMA       Date:  1999-02-03       Impact factor: 56.272

6.  Acyclovir for treatment of infectious mononucleosis: a meta-analysis.

Authors:  D Torre; R Tambini
Journal:  Scand J Infect Dis       Date:  1999

7.  Social class and infectious mononucleosis.

Authors:  F J Nye
Journal:  J Hyg (Lond)       Date:  1973-03

Review 8.  Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.

Authors:  Jeffrey I Cohen
Journal:  Semin Hematol       Date:  2003-04       Impact factor: 3.851

Review 9.  Infectious mononucleosis progressing to fatal malignant lymphoma: a case report and review of the literature.

Authors:  C Kobbervig; D Norback; B Kahl
Journal:  Leuk Lymphoma       Date:  2003-07
  9 in total
  26 in total

1.  Genitourinary manifestations of epstein-barr virus infections.

Authors:  Randi Leigh; Paul Nyirjesy
Journal:  Curr Infect Dis Rep       Date:  2009-11       Impact factor: 3.725

2.  Immunophenotypic profile in acute infectious mononucleosis mimicking malignant lymphoproliferative disorder: a case report and review of literature.

Authors:  Prashant Tembhare; Manisha Ramani; Keerti Syed; Amar Das Gupta
Journal:  Indian J Hematol Blood Transfus       Date:  2010-09-30       Impact factor: 0.900

3.  Erythema multiforme-like lesions in the course of infectious mononucleosis.

Authors:  Vijay Zawar; Antonio Chuh; Sudhir Sankalecha
Journal:  J Dermatol Case Rep       Date:  2009-11-28

4.  Tonsillar CD4+FOXP3+ T-regulatory cell dynamics in primary EBV infection.

Authors:  Yen-Hung Chow; Hsuen-Wen Chang; Raymond Sia; Pele Chong; Charles Sia
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

5.  A Validated Scale for Assessing the Severity of Acute Infectious Mononucleosis.

Authors:  Ben Z Katz; Caroline Reuter; Yair Lupovitch; Kristen Gleason; Damani McClellan; Joseph Cotler; Leonard A Jason
Journal:  J Pediatr       Date:  2019-03-08       Impact factor: 4.406

6.  Simultaneous determination of acyclovir, ganciclovir, and (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine in human plasma using high-performance liquid chromatography.

Authors:  Dennis R Weller; Henry H Balfour; Heather E Vezina
Journal:  Biomed Chromatogr       Date:  2009-08       Impact factor: 1.902

7.  Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis.

Authors:  Suzanne L Elliott; Andreas Suhrbier; John J Miles; Greg Lawrence; Stephanie J Pye; Thuy T Le; Andrew Rosenstengel; Tam Nguyen; Anthony Allworth; Scott R Burrows; John Cox; David Pye; Denis J Moss; Mandvi Bharadwaj
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

8.  Imaging spectrum of EBV-infection in a young patient.

Authors:  P Pelliccia; A Savino; C Cecamore; D Di Marzio; F Chiarelli; A Primavera; C Schiavone
Journal:  J Ultrasound       Date:  2008-03-18

9.  Acquisition and processing of nonhuman primate samples for genetic and phylogenetic analyses.

Authors:  Andrea Kirmaier; William Diehl; Welkin E Johnson
Journal:  Methods       Date:  2009-06-07       Impact factor: 3.608

10.  HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.

Authors:  Karen A McAulay; Craig D Higgins; Karen F Macsween; Annette Lake; Ruth F Jarrett; Faye L Robertson; Hilary Williams; Dorothy H Crawford
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.